article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.

article thumbnail

FDA publishes paper on AI/ML in drug development

European Pharmaceutical Review

The paper is intended to initiate communication with stakeholders, including industry and academia, to foster mutual learning and discussion. Advanced manufacturing “Advanced analytics leveraging AI/ML in the pharmaceutical manufacturing industry offers… possibilities [such as]… enhancing process control… and preventing batch losses.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MIT unlocks real-time powder particle size distribution monitoring

European Pharmaceutical Review

Estimating the appearance of large particles from the continuous monitoring is important for process control, according to the research published in Nature Communications. This limits its application to surfaces encountered in pharmaceuticals manufacturing. Millennium Pharmaceuticals, Inc., Zhang et al.

article thumbnail

Make Paperless Manufacturing a Reality for your Pharmaceutical Facility

PharmaTech

Revolutionize pharmaceutical manufacturing through paperless manufacturing. Even the simplest “paper on glass” digital systems enable streamlined workflows and can ensure real-time data access and seamless communication. Paperless facilities are a reality! Transform your operations today!

article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

We may still continue to send you service-related and other non-promotional communications. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy. Sign up for our daily news round-up!

article thumbnail

EC approves argenx’s efgartigimod alfa for CIDP treatment

Pharmaceutical Technology

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

article thumbnail

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

pharmaphorum

The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels.